SCHEMBL30577482

SCHEMBL30577482

O=c1[nH]c2ccccc2c2[nH]ccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 9/20 0.61
KDM4E B2RXH2 6/20 0.61
ALDH1A1 P00352 4/20 0.61
LMNA P02545 2/20 0.61
GPR3 P46089 2/20 0.61
HSD17B10 Q99714 2/20 0.61
MEN1 O00255 1/20 0.61
TNKS O95271 1/20 0.61
CYP1A2 P05177 1/20 0.61
BLM P54132 1/20 0.61
PMP22 Q01453 1/20 0.61
KMT2A Q03164 1/20 0.61
PARP15 Q460N3 1/20 0.61
TNKS2 Q9H2K2 1/20 0.61
CA12 O43570 1/20 0.53
CA9 Q16790 1/20 0.53
MAPT P10636 1/20 0.50
IDE P14735 1/20 0.50
MPI P34949 1/20 0.50
CACNA1B Q00975 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13738861 1.00 PARP1 (0.61) PARP1KDM4EALDH1A1LMNAGPR3
SCHEMBL2552450 0.86 KDM4E (0.59) PARP1KDM4EALDH1A1LMNAGPR3
SCHEMBL30577488 0.86 KDM4E (0.59) PARP1KDM4EALDH1A1LMNAGPR3
SCHEMBL4555852 0.79 ALDH1A1 (0.59) PARP1KDM4EALDH1A1LMNAGPR3
SCHEMBL21384427 0.78 ALDH1A1 (0.53) PARP1KDM4EALDH1A1LMNAGPR3
SCHEMBL8873438 0.76 PARP1 (0.74) PARP1KDM4EALDH1A1LMNAGPR3
SCHEMBL30090619 0.76 PARP1 (1.00) PARP1KDM4EALDH1A1LMNAGPR3
SCHEMBL17293 0.76 PARP1 (1.00) PARP1KDM4EALDH1A1LMNAGPR3
SCHEMBL31326568 0.76 PARP1 (1.00) PARP1KDM4EALDH1A1LMNAGPR3
SCHEMBL29593478 0.76 PARP1 (1.00) PARP1KDM4EALDH1A1LMNAGPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4490161-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AS PARP INHIBITORS AND THE USE THEREOF Impact Therapeutics (Shanghai), Inc. (CN) 2025-01-15 EP claimed
CN-119013279-A Substituted tricyclic compounds as PARP inhibitors and uses thereof 上海瑛派药业有限公司 2024-11-22 CN claimed
WO-2023169226-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AS PARP INHIBITORS AND THE USE THEREOF Impact Therapeutics (Shanghai), Inc (CN) 2023-09-14 WO claimed
EP-4490161-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AS PARP INHIBITORS AND THE USE THEREOF Impact Therapeutics (Shanghai), Inc. (CN) 2025-01-15 EP disclosed
WO-2025008012-A1 PYRROLOQUINOLINES AND THEIR USE AS TUBULINE ASSEMBLY INHIBITORS UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2025-01-09 WO disclosed
CN-119013279-A Substituted tricyclic compounds as PARP inhibitors and uses thereof 上海瑛派药业有限公司 2024-11-22 CN disclosed
WO-2023169226-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AS PARP INHIBITORS AND THE USE THEREOF Impact Therapeutics (Shanghai), Inc (CN) 2023-09-14 WO disclosed